Occasionally, severe PMD phenotypes were found in females carrying PLP1 mutations, probably attributed to abnormal XCI pattern, other dosage sensitive genes in the duplicated regions, or a changed expression pattern of PLP1 or other genes. This evidence concerns the gene PLP1 and Pelizeaus-Merzbacher spectrum disorder.